What is the recommended protocol for weaning off Seroquel (quetiapine)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 21, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Recommended Protocol for Weaning Off Quetiapine (Seroquel)

The recommended protocol for weaning off quetiapine is a gradual taper of 10% of the original dose per week to minimize withdrawal symptoms, with slower tapering once reaching lower doses. 1

Assessment Before Tapering

  • Evaluate the patient's current dose, duration of use, and reason for discontinuation 2
  • Screen for risk factors that may complicate withdrawal, such as history of psychiatric disorders, previous withdrawal symptoms, or concurrent medications 1
  • For patients taking quetiapine for less than 7 days, discontinuation can generally occur more quickly with minimal risk of withdrawal symptoms 3
  • For patients taking quetiapine for 7-14 days, a more structured but relatively quick taper is needed 3
  • For patients taking quetiapine for more than 14 days, a more gradual tapering protocol is required to minimize withdrawal symptoms 3

Tapering Protocol

For Short-Term Use (< 7 days)

  • May reduce dose by 25-50% every 1-2 days with monitoring for withdrawal symptoms 3

For Intermediate Use (7-14 days)

  • Reduce dose by 20% every 2-3 days 3
  • Example: If taking 300mg daily, reduce to 240mg for 2-3 days, then 180mg for 2-3 days, etc.

For Long-Term Use (> 14 days)

  • Reduce dose by 10% of the original dose per week 1
  • For example, if taking 400mg daily:
    • Week 1: 360mg daily
    • Week 2: 320mg daily
    • Week 3: 280mg daily, and so on 1
  • Once reaching lower doses (typically 50-100mg), slow the taper further to 5% reductions per week 1
  • If on twice-daily dosing, maintain the same dosing schedule during tapering 2

Monitoring During Tapering

  • Monitor for withdrawal symptoms including nausea, vomiting, insomnia, anxiety, irritability, headache, dizziness, and potential rebound psychosis 4
  • If severe withdrawal symptoms occur, pause the taper and maintain the current dose for an additional week before resuming the taper at a slower rate 1
  • Consider using antiemetics like domperidone for managing nausea and vomiting during withdrawal if these symptoms are severe 4
  • For patients with bipolar disorder or schizophrenia, monitor closely for symptom recurrence during the tapering process 5

Special Considerations

  • For elderly patients, use a slower rate of dose reduction (5% per week) due to increased sensitivity to medication changes 2
  • Patients with hepatic impairment may require even more gradual tapering due to altered drug metabolism 2
  • If a patient is taking other psychotropic medications, consider tapering one medication at a time rather than simultaneously 3
  • For patients on high doses (>600mg daily), consider a longer initial stabilization period at each dose reduction 2, 6

Managing Complications

  • If withdrawal symptoms become intolerable, return to the previous well-tolerated dose and resume tapering at a slower rate 1
  • Avoid abrupt discontinuation as it significantly increases the risk of withdrawal symptoms and potential relapse 6
  • If a patient experiences rebound insomnia, consider temporary use of non-benzodiazepine sleep aids rather than increasing quetiapine dose 1
  • For patients who have been on quetiapine for more than a year, the entire tapering process may take several months to complete safely 1, 6

Follow-Up

  • Schedule regular follow-up appointments during the tapering process to monitor progress and adjust the taper as needed 1
  • Once quetiapine is completely discontinued, follow up within 2-4 weeks to ensure stability and absence of delayed withdrawal symptoms 1

References

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.